NCT04497285View on ClinicalTrials.gov

Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

July 30, 2023

Study Completion Date

November 30, 2026

Conditions
Metastatic Breast Cancer
Interventions
OTHER

blood sample collection and collection of tumor tissue block

blood sample collection and collection of tumor tissue block

Trial Locations (1)

08008

Translational Genomics and Targeted Therapeutics in Solid Tumours Lab in August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona

Sponsors
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Guardant Health, Inc.

INDUSTRY

lead

SOLTI Breast Cancer Research Group

OTHER

NCT04497285 - Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter